Please login to the form below

Not currently logged in
Email:
Password:

Medifacts announces USD 6.2m study award

Medifacts International, a US-based provider of non-invasive cardiac safety services, signs a four-year global study worth approximately USD 6.2m

Medifacts International, a US-based provider of non-invasive cardiac safety services, has signed a four-year global study worth approximately USD 6.2m.

The study is a late state registration programme sponsored by a major, but presently unnamed, biotechnology company.

Medifacts will provide comprehensive support for ECG, Holter, as well as ABPM endpoints including provision of equipment for digital collection of cardiac safety data that will be transferred to Medifacts for processing and analysis.

The company will use its proprietary web-based platform, WebHeart, which will enable efficient management of the data and provide a fully-digital environment for manual measurement and overread of ECGs and other cardiac safety and efficacy data while exceeding regulatory guidance and technical standards.

Michael Woehler, Medifacts' CEO, said: "The award represents an endorsement of the tremendous quality of our global services and a continuing vote of long-term confidence in the company by the sponsor community. Our WebHeart platform continues to set the global standard in cardiac safety data collection, management and submission, and we continue to consolidate our position as one of the top five global cardiac safety businesses.î

27th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics